Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Ascorbic acid deficiency and the flavin-containing monooxygenase.

J I Brodfuehrer, V G Zannoni

    Biochemical Pharmacology
    |February 15, 1986
    PubMed
    Summary
    This summary is machine-generated.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Pharmacokinetics of clinafloxacin after single and multiple doses.

    Antimicrobial agents and chemotherapy·2001
    Same author

    Pharmacokinetics of clinafloxacin enantiomers in humans.

    Journal of clinical pharmacology·1999
    Same author

    Achiral and chiral high-performance liquid chromatographic methods for clinafloxacin, a fluoroquinolone antibacterial, in human plasma.

    Journal of chromatography. B, Biomedical sciences and applications·1998
    Same author

    High-performance liquid chromatographic assay for CI-980, a novel 1-deaza-7,8-dihydropteridine anticancer agent, in human plasma and urine.

    Journal of chromatography. B, Biomedical applications·1995
    Same author

    Ascorbic acid deficiency and hepatic UDP-glucuronyl transferase. Qualitative and quantitative differences.

    Biochemical pharmacology·1990
    Same author

    Comparative studies of the in vitro metabolism and covalent binding of 14C-benzene by liver slices and microsomal fraction of mouse, rat, and human.

    Drug metabolism and disposition: the biological fate of chemicals·1990
    Same journal

    Notch signaling in anti-VEGF resistant arteriolar choroidal neovascularization.

    Biochemical pharmacology·2026
    Same journal

    Methylated SNHG3 lncRNA counteracts PSMD4-inhibited angiogenesis by HnRNPA2B1 SUMOylation in peripheral arterial disease.

    Biochemical pharmacology·2026
    Same journal

    The organelle-targeting duality of nanomaterials: physicochemical property-guided therapeutic effects and toxicological outcomes.

    Biochemical pharmacology·2026
    Same journal

    The central role of endoplasmic reticulum stress in Parkinson's disease and targeted therapeutic strategies.

    Biochemical pharmacology·2026
    Same journal

    Mechanisms involved in the regulation of carbohydrate and lipid metabolism by oleanane-type pentacyclic triterpenes.

    Biochemical pharmacology·2026
    Same journal

    Myricitrin alleviates paraquat-induced acute lung injury via PERK pathway to attenuate endoplasmic reticulum stress and mitochondrial dysfunction.

    Biochemical pharmacology·2026
    See all related articles

    Ascorbic acid deficiency significantly reduces flavin-containing monooxygenase (FMO) activity in guinea pigs, impacting drug metabolism. This highlights potential toxicological risks associated with vitamin C deficiency.

    Area of Science:

    • Biochemistry
    • Pharmacology
    • Toxicology

    Background:

    • Flavin-containing monooxygenase (FMO) is crucial for metabolizing various xenobiotics.
    • Ascorbic acid (vitamin C) is essential for many physiological processes, but its role in FMO activity is not fully understood.
    • Ascorbic acid deficiency is known to affect enzyme activities.

    Purpose of the Study:

    • To investigate the impact of ascorbic acid deficiency on flavin-containing monooxygenase (FMO) activity in guinea pigs.
    • To elucidate the specific enzyme responsible for dimethylaniline (DMA) N-oxidation in the context of ascorbic acid deficiency.
    • To explore the toxicological implications of altered FMO activity due to vitamin C deficiency.

    Main Methods:

    • Assessing FMO activity in guinea pigs with varying ascorbic acid levels.

    Related Experiment Videos

  • Measuring the N-oxidation of model substrates like dimethylaniline (DMA) and thiobenzamide.
  • Utilizing enzyme inhibitors (SKF-525A, n-octylamine) and thermal inactivation to differentiate enzyme activities.
  • Conducting kinetic studies (apparent Km) to analyze enzyme behavior.

    • Main Results:

    • Ascorbic acid deficiency significantly reduced FMO activity, correlating with decreased DMA and thiobenzamide oxidation.
    • DMA N-oxidation was found to be mediated by an enzyme distinct from cytochrome P-450, as indicated by thermal stability and pH sensitivity.
    • No significant changes in apparent Km for DMA N-oxidation were observed between supplemented and deficient groups.

    Conclusions:

    • Ascorbic acid deficiency impairs FMO-mediated drug metabolism in guinea pigs.
    • The study suggests FMO, not cytochrome P-450, is primarily responsible for DMA N-oxidation in this model.
    • Reduced FMO activity in vitamin C deficiency may have significant toxicological consequences.